Varlilumab
id:
varlilumab-303-18342257
title:
Varlilumab
text:
Varlilumab is a monoclonal antibody designed for immunotherapy for solid tumors and hematologic malignancies. It is an anti-CD27 antibody and helps activate T-cells. This drug was developed by Celldex Therapeutics. It has undergone a phase 1B clinical trial for advanced breast or ovarian cancer. In combination with anti-PD-1 nivolumab it has undergone a phase 1/2 trial for advanced refractory solid tumours
brand slug:
wiki
category slug:
encyclopedia
description:
Anti-CD27 antibody and helps activate T-cells
original url:
https://en.wikipedia.org/wiki/Varlilumab
date created:
date modified:
2021-12-27T11:50:58Z
main entity:
{"identifier":"Q21098904","url":"https://www.wikidata.org/entity/Q21098904"}
image:
fields total:
13
integrity:
14